DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$85.47
-4.95 (-5.47%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-54.6% upside
Low Target
$27.89
Average Target
$38.82
High Target
$53.79
Current Price
$85.47
Current
$85.47
$85.47
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Scenario Analysis
Bear Case
$27.89
-67.4%
Low target
Base Case
$38.82
-54.6%
Avg target
Bull Case
$53.79
+-37.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$96.50
-11.4% from high
52-Week Low
$16.64
+413.8% from low
50-Day SMA
$45.37
+88.4% vs SMA
200-Day SMA
$31.95
+167.5% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$38.82
-59.8% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-1.09
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |